Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM7A7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,541
Award facts
- Contract value 100% obligated
- $50,540.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $50,540.80 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on December 16, 2025, with completion scheduled for December 17, 2025. This competitively awarded, firm fixed-price delivery order represents a specific pharmaceutical procurement from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The drug will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary pharmaceutical distribution operations.
This delivery order is issued under AmerisourceBergen's comprehensive global pharmaceutical support vehicle with the Defense Logistics Agency, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. Zepbound, a GLP-1 receptor agonist used for weight management, represents the type of specialty medication within AmerisourceBergen's federal medical supply portfolio. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves multiple government healthcare systems through firm fixed-price delivery orders that demonstrate the company's capability to fulfill federal requirements through open competition without set-aside provisions.
Quick answers
Who was awarded contract SPE2DR26FM7A7?
SPE2DR26FM7A7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FM7A7 worth?
The government has obligated $50,541 on SPE2DR26FM7A7.
Is contract SPE2DR26FM7A7 an order under another contract?
Yes. SPE2DR26FM7A7 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM7A7 competed?
The extent of competition for SPE2DR26FM7A7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award